Risk of intracranial aneurysm recurrence after microsurgical clipping based on 3D digital subtraction angiography.

3D digital subtraction angiography aneurysm recurrence aneurysm remnant clipping intracranial aneurysm vascular disorders

Journal

Journal of neurosurgery
ISSN: 1933-0693
Titre abrégé: J Neurosurg
Pays: United States
ID NLM: 0253357

Informations de publication

Date de publication:
01 03 2023
Historique:
received: 10 03 2022
accepted: 16 05 2022
pubmed: 31 7 2022
medline: 4 3 2023
entrez: 30 7 2022
Statut: epublish

Résumé

Current knowledge of recurrence rates after intracranial aneurysm (IA) surgery relies on 2D digital subtraction angiography (DSA), which fails to detect more than 75% of small aneurysm remnants. Accordingly, the discrimination between recurrence and growth of a remnant remains challenging, and actual assessment of recurrence risk of clipped IAs could be inaccurate. The authors report, for the first time, 3D-DSA-based long-term durability and risk factor data of IA recurrence and remnant growth after microsurgical clipping. Prospectively collected data for 305 patients, with a total of 329 clipped IAs that underwent baseline 3D-DSA, were evaluated. The incidence of recurrent IA was described by Kaplan-Meier curves. Risk factors for IA recurrence were analyzed by multivariable Cox proportional hazards and logistic regression models. The overall observed proportion of IA recurrence after clipping was 2.7% (9 of 329 IAs) at a mean follow-up of 46 months (0.7% per year). While completely obliterated IAs did not recur during follow-up, incompletely clipped aneurysms (76 of 329) demonstrated remnant growth in 11.8% (3.4% per year). Young age and large initial IA size significantly increased the risk of IA recurrence. The findings support those in previous studies that hypothesized that completely clipped IAs have an extremely low risk of recurrence. Conversely, the results highlight the significant risk posed by incompletely clipped IAs. Young patients with initial large IAs and incomplete obliteration have an especially high risk for IA recurrence and therefore should be monitored more closely.

Identifiants

pubmed: 35907194
doi: 10.3171/2022.5.JNS22424
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

717-723

Auteurs

Serge Marbacher (S)

1Department of Neurosurgery, Kantonsspital Aarau, University of Bern.

Basil Erwin Grüter (BE)

1Department of Neurosurgery, Kantonsspital Aarau, University of Bern.
2Division of Neurosurgery, Kantonsspital Aarau, University of Bern, and.

Stefan Wanderer (S)

1Department of Neurosurgery, Kantonsspital Aarau, University of Bern.

Lukas Andereggen (L)

1Department of Neurosurgery, Kantonsspital Aarau, University of Bern.

Marco Cattaneo (M)

3Clinical Trial Unit, Department of Clinical Research, University of Basel, University Hospital Basel, Switzerland.

Patricia Trost (P)

1Department of Neurosurgery, Kantonsspital Aarau, University of Bern.

Philipp Gruber (P)

2Division of Neurosurgery, Kantonsspital Aarau, University of Bern, and.

Michael Diepers (M)

2Division of Neurosurgery, Kantonsspital Aarau, University of Bern, and.

Luca Remonda (L)

2Division of Neurosurgery, Kantonsspital Aarau, University of Bern, and.

Hans-Jakob Steiger (HJ)

1Department of Neurosurgery, Kantonsspital Aarau, University of Bern.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH